Determinants of progression of HIV infection in a Greek hemophilia cohort followed for up to 16 years after seroconversion

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 19, Issue 1, 1998, Pages 89-97

  Touloumi, Giota ^a   Karafoulidou, Anastasia ^b   Gialeraki, Argiri ^b   Katsarou, Olga ^b   Milona, Ioanna ^a   Kapsimali, Violetta ^c   Mandalaki, Titika ^b   Hatzakis, Angelos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

^c EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Age; All cause mortality; Cytomegalovirus; Hemophilia; HIV infection; Progression to AIDS

Indexed keywords

CD4 ANTIGEN; CYTOMEGALOVIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAIN HEMORRHAGE; COHORT ANALYSIS; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; FOLLOW UP; GREECE; HEMOPHILIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER FAILURE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SEROCONVERSION;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032169159     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199809010-00014     Document Type: Article

References (46)

1. Moss AR, Bacchetti P, Osmond D, et al. Seropositivity for HIV and the development of AIDS or AIDS related conditions: three year follow up of the San Francisco General Hospital Cohort. BMJ 1988;296:745-50.
2. Munoz A, Wang MC, Bass S, et al. AIDS-free time after HIV-1 seroconversion in homosexual men. Am J Epidemiol 1989;130: 530-9.
3. Goedert JJ, Kessler CM, Aledort LM, et al. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with haemophilia. N Engl J Med 1989; 321:1141-8.
4. Lee CA, Phillips AN, Elford J, Janossy G, Griffiths P, Kernoff P. Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment. BMJ 1991;303:1093-6.
5. Biggar RJ and the International Registry of Seroconverters. AIDS incubation in 1891 HIV seroconverters from different exposure groups. AIDS 1990;4:1059-66.
6. Schinaia N, Ghirardini A, Chiarotti F, Gringeri A, Mannucci PM, and the Italian Group. Progression to AIDS among Italian HIV-seropositive haemophiliacs. AIDS 1991;5:385-91.
7. The Italian Seroconversion Study. Disease progression and early predictors of AIDS in HIV-seroconverted injecting drug users. AIDS 1992;6:421-6.
8. Veugelers PJ, Page KA, Tindall B, et al. Determinants of HIV disease progression among homosexual men registry in the Tricontinental Seroconverter Study. Am J Epidemiol 1994;140:747-58.
9. Hatzakis A, Karafoulidou A, Touloumi G, et al. Determinants of progression in a haemophilia cohort followed for 14 years. X International Conference on AIDS, Yokohama, Japan, 1994.
10. Brettle RP, McNeil AJ, Burns S, et al. Progression of HIV: follow-up of Edinburgh injecting drug users with narrow seroconversion intervals in 1983-1985. AIDS 1996;10:419-30.
11. Darby S, Rizza CR, Doll R, Spooner RJD, Stratton IM, Thakrar B. Incidence of AIDS and excess mortality associated with HIV in haemophiliacs in the United Kingdom: report on the behalf of the directors of haemophilia centers in the United Kingdom. BMJ 1989;298:1064-8.
12. Sabin CA, Phillips AN, Bhagani S, Pasi KJ, Elford J, Lee CA. The progression of HIV infection in a cohort of haemophilic men followed for up to 16 years after seroconversion. XI International Conference on AIDS, Vancouver, British Columbia, Canada, 1996.
13. Osmond D, Charlebois E, Lang W, Shiboski S, Moss A. Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993. JAMA 1994;271:1083-7.
14. Blum S, Singh TP, Gibbons J, et al. Trends in survival among persons with acquired immunodeficiency syndrome in New York City. Am J Epidemiol 1994;139:351-61.
15. Saah AJ, Hoover DR, He Y, Kingsley LA, Phair JP, and the Multicenter AIDS Cohort Study (MACS). Factors influencing survival after AIDS: report from the Multicenter AIDS Cohort Study (MACS). J Acquir Immune Defic Syndr 1994;7:287-95.
16. Ghirardini A, Puopolo M, Rossetti G, et al. Survival after AIDS among Italian haemophiliacs with HIV infection. AIDS 1995;9: 1351-6.
17. Centers for Diseases Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morbid Mortal Wkly Rep 1992;41:1-19.
18. Koumbarelis E, Rosendaal FR, Gialerali A, et al. Epidemiology of haemophilia in Greece: an overview. Thromb Haemost 1994;72: 808-13.
19. Darby SC, Ewart DW, Giangrande PLF, Dolin PJ, Spooner RJD, Rizza CR, on behalf of the UK Haemophilia Centre Director's Organization. Mortality before and after HIV infection in the complete UK population of haemophiliacs. Nature 1995;377:79-82.
20. Sabin C, Phillips A, Elford J, Griffiths P, Janossay G, Lee C. The progression of HIV disease in a haemophilic cohort followed for 12 years. Br J Haematol 1993;83:330-3.
21. Goedert JJ, Pizza G, Gritti FM, et al. Mortality among drug users in the AIDS era. Int J Epidemiol 1995;42:1204-10.
22. Darby SC, Ewart DW, Giangrande PLF, Spooner RJD, Rizza CR, for the UK Haemophilia Centre Director's Organization. Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. Lancet 1996;347:1573-9.
23. Diamondstone LS, Blakley SA, Rice JC, Clark RA, Goedert JJ. Prognostic factors of all-cause mortality among haemophiliacs infected with human immunodeficiency virus. Am J Epidemiol 1995; 142:304-13.
24. Phillips AN, Lee CA, Elford J, et al. More rapid progression to AIDS in older HIV-infected people: the role of CD4 T-cell counts. J Acquir Immune Defic Syndr 1991;4:970-5.
25. Rosenberg PS, Goedert JJ, Bigar RJ for the Multicenter Cohort Study and the International Registry of Seroconverters. Effect of age at seroconversion on the natural AIDS incubation distribution. AIDS 1994;8:803-10.
26. Carré N, Deveau C, Belanger F, et al. Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. AIDS 1994;8:797-802.
27. Martin JN, Colford JM Jr, Ngo L, Tager IB. Effect of older age on survival in human immunodeficiency virus (HIV) disease. Am J Epidemiol 1995;142:1221-30.
28. Pezzotti P, Phillips AN, Dorrucci M, et al. Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion. BMJ 1996;313: 583-6.
29. Touloumi G, Hatzakis A, Karafoulidou A, et al. The slope of change in CD4 counts as prognostic factor in the progression of HIV infection. X International Conference on AIDS, Yokohama, Japan, 1994.
30. Jackson JB, Erice A, Englund JA, Edson JR, Balfour HH. Prevalence of cytomegalovirus antibody in haemophiliacs and homosexuals infected with human immunodeficiency virus type 1. Transfusion 1988;28:187-9.
31. Rugman FP, Mannion PT, Hay CRM, Bolton-Maggs P, Roberts D, Mutton KJ. Cytomegalovirus, serum beta-2-microglobulin, and progression to AIDS in HIV-seropositive hemophiliacs. Lancet 1989;2:631.
32. Becherer PR, Smiley ML, Mathews TJ, Weinhold KJ, McMillan CW, White GC. Human immunodeficiency virus-1 disease progression in hemophiliacs. Am J Hematol 1990;34:204-9.
33. Rabkin CS, Hatzakis A, Griffiths PD, et al. Cytomegalovirus infection and risk of AIDS in human immunodeficiency virus-infected hemophilia patients. J Infect Dis 1993;168:1260-3.
34. Sabin CA, Phillips AN, Lee CA, Janossy G, Emery V, Griffiths PD. The effect of CMV infection on progression of human immunodeficiency virus disease in a cohort of haemophilie men followed for up to 13 years from seroconversion. Epidemiol Infect 1995;114:361-72.
35. Kroner BL, Rosenberg PS, Aledort LM, Alvord WG, Goedert JJ, for the Multicenter Hemophilia Cohort Study. HIV-1 infection incidence among persons with hemophilia in the United States and Western Europe, 1978-1990. J Acquir Immune Defic Syndr 1994; 7:279-86.
36. Schinaia N, Ghirardini AM, Mazzucconi MG, Tagariello G, Morfini M, Chiarotti F. Clinical factors associated with progression to AIDS in the Italian cohort of HIV-positive hemophiliacs. Thromb Haemost 1994;72:33-8.
37. Hatzakis A, Polychronaki H, Miriagou V, et al. Antibody responses to Hepatitis C Virus by second-generation immunoassays in a cohort of patients with bleeding disorders. Vox Sang 1992;63: 204-9.
38. Fletcher ML, Trowell JM, Craske J, Pavier K, Rizza CR. Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients. BMJ 1983;287:1754-7.
39. Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ, for the Multicenter Hemophilia Study. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. J Acquir Immune Defic Syndr 1993;6:602-10.
40. Marrioto AB, Mariotti S, Pezzotti P, Rezza G, Verdecchia A. Estimation of the acquired immunodeficiency syndrome incubation period in intravenous drug users: a comparison with male homosexuals. Am J Epidemiol 1992;135:428-37.
41. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-22.
42. - T-lymphocytes regeneration after intensive chemotherapy. N Engl J Med 1995;332:143-9.
43. Mellors JW, Rinaldo CH, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.
44. O'Brien TR, Blattner WA, Waters D, et al. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA 1996;276:105-110.
45. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of CKR5 structural gene. Science 1996;273:1856-62.
46. Nasioulas G, Dean M, Koumbarelis E, et al. Allele frequency of the CCR5 mutant chemokine receptor in Greek Caucasians. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:181-2.